Chien-ching H. Hung
Expertise in
11
conditions

Chien-ching H. Hung

National Taiwan University Hospital Hsin Chu Branch
Hsinchu, TNQ, TW 
Expertise in
11
conditions
National Taiwan University Hospital Hsin Chu Branch
Hsinchu, TNQ, TW 

Overview

Chien-ching Hung practices practicing medicine in Hsinchu, Taiwan.

Hung is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Hepatitis A, HIV/AIDS, Syphilis, and Hepatitis.

They are actively involved in clinical research, co-authoring 288 peer reviewed articles and participating in 1 clinical trial.

Locations

National Taiwan University Hospital Hsin Chu Branch
Hsinchu, TNQ, Taiwan
Other Locations
7 Chung Shan South Road, TPQ 10002, Taiwan
No. 7, Chung Shan South Road, 1000, TPQ, Taiwan
7 Chung Shan South Road, 100, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Drug
Study Phase: Phase 3

288 Total Publications

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
Journal: The New England journal of medicine
Published: July 29, 2026

Frequently Asked Questions about Chien-ching H. Hung

Is Chien-ching H. Hung a top-rated expert for Hepatitis A?

MediFind is an objective health platform that identifies experts based on real-world data. Chien-ching H. Hung is classified as an Distinguished expert for Hepatitis A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chien-ching H. Hung participate in research or clinical trials?

Yes. Chien-ching H. Hung has published 288 articles and abstracts on conditions like Hepatitis A. You can view a list of Chien-ching H. Hung's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hung's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile